Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Asian Biomedicine
Volume 8 (2014): Issue 3 (June 2014)
Open Access
Original article. Potential risk of dihydroergotamine causing medicationoveruse headache: preclinical evidence
Suteera Vibulyaseck
Suteera Vibulyaseck
,
Saknan Bongsebandhu-phubhakdi
Saknan Bongsebandhu-phubhakdi
,
Supang Maneesri le Grand
Supang Maneesri le Grand
and
Anan Srikiatkhachorn
Anan Srikiatkhachorn
| Feb 04, 2017
Asian Biomedicine
Volume 8 (2014): Issue 3 (June 2014)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Feb 04, 2017
Page range:
323 - 331
DOI:
https://doi.org/10.5372/1905-7415.0802.296
Keywords
Cortical excitability
,
cortical spreading depression
,
CSD
,
c-Fos expression
,
dihydroergotamine
,
DHE
,
medication-overuse headache
,
MOH
,
trigeminal nociception
© 2017
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.